BP Meds No Help Against Colorectal Cancer - MedPage Today

BP Meds No Help Against Colorectal Cancer MedPage Today Note that a positive association was found for stage IV colorectal cancer and long-term use (6 or more years) of beta-blockers when compared with non-use. Long-term use of common beta-blocker drugs to combat high blood pressure does not decrease the ... Company Profile for Fight Colorectal CancerMarketWatch (press release) Get Your Rear In Gear13abc Action News all 5 news articles »

Experts Debate Pros and Cons of Molecular Profiling for Colon Cancer - General Surgery News

General Surgery News

Experts Debate Pros and Cons of Molecular Profiling for Colon Cancer General Surgery News San Francisco—Is molecular profiling for stage II colon cancer ready for prime time? If you ask many oncologists and surgical oncologists, you will not find a consensus. At the recent Gastrointestinal Cancers Symposium, two experts faced off on this ...

Colorectal Cancer: Robin Gibb, Bee Gees Singer, Is Battling The Disease, But ... - Huffington Post

Colorectal Cancer: Robin Gibb, Bee Gees Singer, Is Battling The Disease, But ... Huffington Post Like many other cancers, colorectal cancer severity is defined by stages. Stage 1 means that the cancer hasn't spread at all past the colon's wall or the rectum, while stage 2 means that the cancer has grown in the colon wall or rectal wall, ... and more »

The effect of laparoscopic surgery in stage II and III right-sided colon ... - 7thSpace Interactive (press release)

The effect of laparoscopic surgery in stage II and III right-sided colon ... 7thSpace Interactive (press release) This retrospective study compared the clinicopathological results among three groups dividedby time sequence to evaluate the impact of introducing laparoscopic surgery on long-termoncological outcomes for right-sided colon cancer.

Merck KGaA's colon cancer drug fails trial - InPharm

Merck KGaA's colon cancer drug fails trial InPharm Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial. Researchers were looking at Erbitux (cetuximab) in the adjuvant treatment of stage III colon cancer after surgical removal of the ...